Company / Interest Expense per Share
Jazz Pharmaceuticals Interest Expense per Share History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.52
FY2023
5-year range
$0.52 / $1.42
FY2019-FY2023
Trend
-63.5%
vs FY2022
Sector context
#9 of 43
Health Care
What the data says
Jazz Pharmaceuticals's interest expense per share of $0.52 is higher than 79% of companies in the Health Care sector (FY2023). Improved from $1.11 to $0.52 over the past 2 years.
Based on SEC 10-K filings.
0.52 in FY2023 with a 5-year CAGR of +2.1%. Top quartile in the Health Care sector.
Improved from $1.11 to $0.52 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -19.9%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 43This company $0.52 Sector average $9.80
▼
-94.7% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 63.5% year-over-year.
- Ranks #9 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2022.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.52 | -63.5% |
| FY2022 | $1.42 | +27.7% |
| FY2021 | $1.11 | +10.2% |
| FY2020 | $1.01 | +54.2% |
| FY2019 | $0.66 | +40.3% |
| FY2018 | $0.47 | -26.1% |
| FY2017 | $0.63 | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026